This fact sheet is for men who are thinking about having surgery to treat their prostate cancer.
Last updated: September 2014 To be reviewed: September 2016
Abdollah F, Sun M, Suardi N, et al. Prediction of functional outcomes after nerve-sparing radical prostatectomy: Results of conditional survival analyses. Eur Urol 2012
Berookhim BM, Nelson CJ, Kunzel B, et al.Prospective analysis of penile length changes after radical prostatectomy. BJU Int 2014;113(5b):E131-6.
Boorjian SA, Eastham JA, Graefen M, et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 2012;61(4):664-75.
Boorjian SA, Karnes RJ, Crispen PL, et al. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era.J Urol 2010;183(3):1003-9.
Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int 2010;106(11):1734–8.
Campbell SE, Glazener CMA, Hunter KF, et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database of Systematic Reviews2012, Issue 1.
Coelho RF, Rocco B, Patel MB, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: A critical review of outcomes reported by high-volume centers. J Endourol 2010;24(12):2003–15.
Cooper A. Robotic assisted radical prostatectomy – Evidence Summary. Prostate Cancer UK. January 2014.
Cornell D. A gay urologist’s changing views of prostate cancer. In: Perlman G, Drescher J.(editors). A gay man’s guide to prostate cancer. The Haworth Medical Press; Binghamton, NY 2005;29-41.
Dalkin BL, Christopher BA. Preservation of penilelengthafterradicalprostatectomy: early intervention with a vacuum erection device. Int J Impot Res 2007;19(5):501-4.
Garcia FJ, Brock G. Current state of penile rehabilitation after radical prostatectomy. Curr Opin Urol 2010;20:234-40.
Goldstone SE. The ups and downs of gay sex after prostate cancer treatment. In: Perlman G, Drescher J. (editors). A gay man’s guide to prostate cancer. The Haworth Medical Press; Binghamton, NY 2005;43-55.
Guttilla A, Bortolus R, Giannarini G, et al. Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial. Radiat Oncol 2014;9:24.
Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. AnnOncol 2011;22(4):761-72.
Anderson JB, Clarke NC, Gillatt D, et al. Advice on the development of robotic assisted radical prostatectomy in England. Prostate Cancer Advisory Group. 2012.
Kilminster S, MüllerS, MenonM, et al. Predicting erectile function outcome in men after radical prostatectomy for prostate cancer. BJU Int 2012;110:422–26.
Levinson AW, LaveryHJ, Ward NT, et al. Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy. World J Urol 2011;29:29–34.
Lim SK. Current status of robot-assisted laparoscopic radical prostatectomy: how does it compare with other surgical approaches? Int J Urol 2013;20(3):271-84.
Moran PS, O’Neill M, Teljeur C, et al. Robot-assisted radical prostatectomy compared with open and laparoscopic approaches: A systematic review and meta-analysis. Int J Urol 2013;20(3):312–21.
Mottet N, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer. European Association of Urology. 2014.
Multi-disciplinary team (MDT) guidance for managing prostate cancer. British Uro-oncology Group, British Association of Urological Surgeons: Section of Oncology. September 2013.
Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control 2014;3(23).
Parsons BA, Evans S, Wright MP. Prostate cancer and urinary incontinence. Maturitas 2009;63:323-28.
Perio-operative management of the morbidly obese patient. The Association of Anaesthetists of Great Britain and Ireland. June 2007.
Prostate cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence (NICE). Clinical guideline 175. January 2014.
Robotic Assisted (Da Vinci) Radical Prostatectomy. The Royal Marsden NHS Foundation Trust. April 2013.
Robotic radical prostate removal for cancer – information for patients. The British Association of Urological Surgeons. March 2014.
Thomas C, Wotten A, Robinson P. The experiences of gay and bisexual men diagnosed with prostate cancer: results from an online focus group. Eur JCancer Care 2013;22:522-29.
Venous thromboembolism: reducing the risk. National Institute for Health and Clinical Excellence (NICE). Clinical guideline 92. January 2010.
Vesey SG, McCabe JE, Hounsome L, Fowler S. UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database. BJU Int 2012;109(3):346-54.
Warfarin Therapy - Management During Invasive Procedures and Surgery. BC Guidelines. 2010.
Zippe CD, Pahlajani G. Vacuum erection devices to treat erectile dysfunction and early penile rehabilitation following radical prostatectomy. Current Urol Reports 2008;9(6):506-13.
This fact sheet is for men who want to know more about urinary problems after treatment for prostate cancer. It explains how different treatments for prostate cancer may cause problems urinating (peeing) and leaking urine. It also describes ways to manage these problems.